Fast & capital efficient path to market with a razor/razor blade model:

- Disinfection device (510k, no patient contact, ID'ed predicate)

- Consumable disinfectant (already FDA cleared, high margins)

Direct sales model using our Founder's established sales networks within target field (ultrasound probes)

Initial device protected by broad, issued patent claims. Additional claims filed.

Seeking up to $3M convertible note Seed funding.